SIETES :: 92826 citas

Resultados de la búsqueda por CONSULTA TERAPÉUTICA REFINAR BÚSQUEDA

1.

Dandjinou M, Sheehy O, Bérard A. Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case–control study. BMJ Open 2019;9:e025908. [Ref.ID 103190]

2.

Freund Y, Goulet H, Lebland J, Bokobza J, Ray P, Maignan M, Guinemer S, Truchot J, Féral-Pierssens A-L, Yordanov Y, Philippon A-L, Rouff E, Bloom B, Cachanado M, Rousseau A, Simon T, Riou B. Effect of systematic physician cross-checking on reducing adverse events in the emergency department. The CHARMED cluster randomized trial. JAMA Intern Med 2018;178:junio. [Ref.ID 102771]

3.

Bromley RL, Weston J, Marson AG. Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children. JAMA 2017;318:1700-1. [Ref.ID 102140]

4.

Bérard A, Sheehy O, Zhao J-P, Vinet É, Bernatsky S, Abrahamowicz M. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn. Br J Clin Pharmacol 2017;83:1126-33. [Ref.ID 101973]

5.

Salat D, Llop R, Aguilera C, Danés I, Bosch M, Asensio C, Castañeda F, Esterlich E, Vallano A. Therapeutics enquiries about biological agents as a tool to identify safety aspects and patterns of use. European Journal of Hospital Pharmacy 2016;23:161-5. [Ref.ID 100163]

6.

Taegtmeyer AB, Curkovic I, Rufibach K, Corti N, Battegay E, Kullak-Ublick GA. Electronic prescribing increases uptake of clinical pharmacologists' recommendations in the hospital setting. Br J Clin Pharmacol 2011;72:958-64. [Ref.ID 91875]

7.

Erdeljic V, Francetic I, Makar-Ausperger K, Likic R, Radacic-Aumiler M. Clinical pharmacology consultation: a better answer to safety issues of drug therapy during pregnancy?. Eur J Clin Pharmacol 2010;66:1037-46. [Ref.ID 89445]

8.

Gendron MP, Martin B, Oraichi D, Bérard A. Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation. Eur J Clin Pharmacol 2009;65:523-31. [Ref.ID 85831]

9.

Hedegaard U, Damkier P. Problem-oriented drug information: physicians' expectations and impact on clinical practice. Eur J Clin Pharmacol 2009;65:515-22. [Ref.ID 85830]

10.

Frost Widnes SK, Schjott J. Drug use in pregnancy - physician's evaluation of quality and clinical impact of drug information centres. Eur J Clin Pharmacol 2009;65:303-8. [Ref.ID 85449]

11.

López F, Romans C, Aguilera C. Therapeutic consultation service about teratogens. A pilot study. Basic Clin Pharmacol Toxicol 2006;99:46. [Ref.ID 78400]

12.

Durán M, Pérez E, Ballarín E, Vidal X, Laporte JR, Capellà D. Therapeutic use of cannabis: review and synthesis of the evidence, information, and institutional collaborative research in Catalonia. Basic Clin Pharmacol Toxicol 2006;99:24. [Ref.ID 78388]

13.

Sullivan F, Wyatt JC. Is a consultation needed?. BMJ 2005;331:625-7. [Ref.ID 74813]

14.

Bergk V, Gasse C, Schnell R, Haefeli WE. Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany. Eur J Clin Pharmacol 2004;60:595-602. [Ref.ID 71969]

15.

von Mach MA, Meyer S, Omogbehin B, Kann PH, Weilemann LS. Epidemiological assessment of 160 cases of insulin overdose recorded in a regional poisons unit. Int J Clin Pharmacol Ther 2004;42:277-80. [Ref.ID 70114]

16.

Eklöf AC, Thurelius AM, Garle M, Rane A, Sjöqvist F. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol 2003;59:571-7. [Ref.ID 68148]

17.

Haller CA, Anderson IB, Kim SY, Blanc PD. An evaluation of selected herbal reference texts and comparison to published reports of adverse herbal events. Adverse Drug React Toxicol Rev 2002;21:143-50. [Ref.ID 62144]

18.

Figueras A, Laporte JR. Therapeutic consultation centres are helpful in developing countries. BMJ 2002;324:236. [Ref.ID 60218]

19.

Pedrós C, Agustí A. La consulta farmacoterapéutica como fuente para detectar y prevenir reacciones adversas a medicamentos en el ámbito hospitalario. Archivos de la Facultad de Medicina de Zaragoza 2001;41:21-3. [Ref.ID 56585]

20.

Brassey J, Elwyn G, Price C, Kinnersley P. Just in time information for clinicians: a questionnaire evaluation of the ATTRACT project. BMJ 2001;322:529-30. [Ref.ID 55395]